Home8CB0 • FRA
add
Cannara Biotech Inc
Previous close
€1.08
Day range
€1.05 - €1.07
Year range
€0.69 - €1.24
Market cap
175.36M CAD
Avg Volume
462.00
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Revenue | 27.18M | 2.72% |
Operating expense | 8.25M | 35.67% |
Net income | 1.66M | -49.84% |
Net profit margin | 6.12 | -51.16% |
Earnings per share | 0.02 | — |
EBITDA | 4.64M | -36.51% |
Effective tax rate | 41.04% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.90M | 333.25% |
Total assets | 181.81M | 12.64% |
Total liabilities | 61.60M | -8.36% |
Total equity | 120.21M | — |
Shares outstanding | 96.36M | — |
Price to book | 0.86 | — |
Return on assets | 4.78% | — |
Return on capital | 5.66% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Net income | 1.66M | -49.84% |
Cash from operations | 2.95M | 215.61% |
Cash from investing | -3.01M | -115.24% |
Cash from financing | 5.44M | 532.33% |
Net change in cash | 5.39M | 203.45% |
Free cash flow | -1.28M | 81.66% |
About
Founded
2017
Website
Employees
452
